Physician
Pediatric Infectious Disease
Dr. Rohan Hazra, MD
|
|
Give Review
Rohan Hazra works in the field of Pediatric Infectious Disease. He went to Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical university. Johns Hopkins University School of Medicine has a rank of 3 in research and a 29 in primary care Rohan Hazra is a published doctor. He has 60 publications published. The most current publication "Neurologic outcomes in HIV-exposed/uninfected infants exposed to antiretroviral drugs during pregnancy in Latin America and the Caribbean."
Publications
- Acylcarnitine profiles in HIV-exposed, uninfected neonates in the United States.
- Commentary: the place of tenofovir disoproxil fumarate in pediatric antiretroviral therapy.
- Relationship between viral load and behavioral measures of adherence to antiretroviral therapy in children living with human immunodeficiency virus in Latin America.
- Early viral suppression improves neurocognitive outcomes in HIV-infected children.
- Immunodeficiency in children starting antiretroviral therapy in low-, middle-, and high-income countries.
- Safety of In Utero and Neonatal Antiretroviral Exposure: Cognitive and Academic Outcomes in HIV-exposed, Uninfected Children 5-13 Years of Age.
- Congenital Anomalies and In Utero Antiretroviral Exposure in Human Immunodeficiency Virus-Exposed Uninfected Infants.
- Kidney dysfunction among HIV-infected children in Latin America and the Caribbean.
- Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youth treated with tenofovir disoproxil fumarate.
- Biomarkers and neurodevelopment in perinatally HIV-infected or exposed youth: a structural equation model analysis.
- Association of higher plasma vitamin D binding protein and lower free calcitriol with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmaco...
- Undervaccination of Perinatally HIV-infected and HIV-exposed Uninfected Children in Latin America and the Caribbean.
- Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment.
- Development and validation of the first liquid chromatography-tandem mass spectrometry assay for simultaneous quantification of multiple antiretrovirals in meconium.
- Combination antiretroviral use and preterm birth.
- Insulin Resistance and Glucose and Lipid Concentrations in a Cohort of Perinatally HIV-Infected Latin American Children.
- Preexposure Prophylaxis for Adolescents and Young Adults at Risk for HIV Infection: Is an Ounce of Prevention Worth a Pound of Cure?
- Sexual risk behavior among youth with perinatal HIV infection in the United States: predictors and implications for intervention development.
- Bone mineral density in children and adolescents with perinatal HIV infection.
- Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants.
- Evaluation of viral load thresholds for predicting new World Health Organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral t...
- Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein.
- HIV Drug Resistance-Associated Mutations in Antiretroviral Naïve HIV-1-Infected Latin American Children.
- Factors associated with insulin resistance among children and adolescents perinatally infected with HIV-1 in the pediatric HIV/AIDS cohort study.
- Lipid levels in the second year of life among HIV-infected and HIV-exposed uninfected Latin American children.
- In Utero and Postnatal Exposure to Antiretrovirals Among HIV-Exposed But Uninfected Children in the United States.
- Family functioning and coping styles in families of children with cancer and HIV disease.
- Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposure.
- Steady-state pharmacokinetics of tenofovir-based regimens in HIV-infected pediatric patients.
- Clinical management and follow-up of hypercholesterolemia among perinatally HIV-infected children enrolled in the PACTG 219C study.
- CD4+ lymphocyte-based immunologic outcomes of perinatally HIV-infected children during antiretroviral therapy interruption.
- Type 2 diabetes and impaired glucose tolerance in two young adults infected with HIV early in life.
- HIGH RATE OF CORONARY ARTERY ABNORMALITIES IN ADOLESCENTS AND YOUNG ADULTS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS EARLY IN LIFE.
- Long-term outcomes for HIV-infected infants less than 6 months of age at initiation of lopinavir/ritonavir combination antiretroviral therapy.
- Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T ly...
- Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhood.
- Dyslipidemia in a cohort of HIV-infected Latin American children receiving highly active antiretroviral therapy.
- Characteristics of HIV infected adolescents in Latin America: results from the NISDI pediatric study.
- Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youth.
- Correlates of spontaneous viral control among long-term survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57.
- Both human immunodeficiency virus-infected and human immunodeficiency virus-exposed, uninfected children living in Brazil, Argentina, and Mexico have similar rates of ...
- Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes ...
- Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection.
- Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacy.
- Cohort Profile: NICHD International Site Development Initiative (NISDI): a prospective, observational study of HIV-exposed and HIV-infected children at clinical sites ...
- Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus.
- Virologic response using directly observed therapy in adolescents with HIV: an adherence tool.
- Evidence of human immunodeficiency virus type 1 infection of nestin-positive neural progenitors in archival pediatric brain tissue.
- Immunologic, virologic, and neuropsychologic responses in human immunodeficiency virus-infected children receiving their first highly active antiretroviral therapy reg...
- Emergence of human immunodeficiency virus type 1 variants containing the Q151M complex in children receiving long-term antiretroviral chemotherapy.
- Cognitive functioning in school-aged children with vertically acquired HIV infection being treated with highly active antiretroviral therapy (HAART).
- Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children.
- Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy for pediatric HIV infection.
- Thymic function in HIV infection.
- HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response.
- Transcription regulation by the Mycobacterium tuberculosis alternative sigma factor SigD and its role in virulence.
- Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, ...
- Single-dose and steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected children.
- Neurologic outcomes in HIV-exposed/uninfected infants exposed to antiretroviral drugs during pregnancy in Latin America and the Caribbean.
Schools
Johns Hopkins University School of Medicine
Children39s Hospital Boston
Doctors Specialties
- Pediatric Infectious Disease Medicine
- Pediatric Infectious Disease
Accepted Insurances
Education
-
Boston Children's Hospital -
Johns Hopkins University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Hasan S. Jafri, MB
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Margaret C. Bash, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Shapiro, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allison M. Malloy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel J. Adams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark Connors, MD |
|
|
Dr. Margan J. Zajdowicz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven E. Spencer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Merlin L. Robb, MD |
|
|
Dr. Leslie K. Ball, MD
This Doctor is OpenDoctor Recommended.
|